Stathmin expression predicts response to taxanes in metastatic endometrial cancer

被引:1
作者
Werner, Henrica M. J. [1 ]
Trovik, Jone [1 ]
Wik, Elisabeth [1 ]
Akslen, Lars A. [2 ]
Salvesen, Helga B. [1 ]
机构
[1] Univ Bergen, Bergen, Norway
[2] Gade Inst, Bergen, Norway
关键词
D O I
10.1158/1538-7445.AM2011-3158
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3158
引用
收藏
页数:1
相关论文
共 50 条
[31]   Response rates of taxane rechallenge in metastatic breast cancer patients previously treated with adjuvant taxanes [J].
Kucukoztas, Nadire ;
Oguz, Arzu ;
Rahatli, Samed ;
Altundag, Ozden ;
Altundag, Kadri .
JOURNAL OF BUON, 2016, 21 (05) :1076-1081
[32]   Therapeutic potential of taxanes in the treatment of metastatic pancreatic cancer [J].
Lemstrova, Radmila ;
Melichar, Bohuslav ;
Mohelnikova-Duchonova, Beatrice .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (06) :1101-1111
[33]   Use and abuse of taxanes in the management of metastatic breast cancer [J].
Bernard-Marty, C ;
Cardoso, F ;
Piccart, MJ .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (14) :1978-1989
[34]   PDEF downregulates stathmin expression in prostate cancer [J].
Sabherwal, Yamini ;
Mahajan, Nitin ;
Helseth, Donald L. ;
Gassmann, Mayumi ;
Shi, Heidi ;
Zhang, Ming .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (06) :1889-1899
[35]   Protein profiling predicts the response to anthracycline and taxanes based neo-adjuvant chemotherapy in breast cancer [J].
Shu Wang ;
Houpu Yang ;
Jiajia Guo ;
Miao Liu ;
Fuzhong Tong ;
Yingming Cao ;
Bo Zhou ;
Peng Liu ;
Hongjun Liu ;
Lin Cheng ;
Fei Xie ;
Deqi Yang ;
Jiaqing Zhang .
BioChip Journal, 2011, 5 :32-38
[36]   Protein profiling predicts the response to anthracycline and taxanes based neo-adjuvant chemotherapy in breast cancer [J].
Wang, Shu ;
Yang, Houpu ;
Guo, Jiajia ;
Liu, Miao ;
Tong, Fuzhong ;
Cao, Yingming ;
Zhou, Bo ;
Liu, Peng ;
Liu, Hongjun ;
Cheng, Lin ;
Xie, Fei ;
Yang, Deqi ;
Zhang, Jiaqing .
BIOCHIP JOURNAL, 2011, 5 (01) :32-38
[37]   ZEB1 Expression in Endometrial Biopsy Predicts Lymph Node Metastases in Patient with Endometrial Cancer [J].
Feng, Gang ;
Wang, Xiangming ;
Cao, Xiaozhi ;
Shen, Lijuan ;
Zhu, Jiansheng .
DISEASE MARKERS, 2014, 2014
[38]   Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer [J].
Baker, J. B. ;
Dutta, D. ;
Watson, D. ;
Maddala, T. ;
Munneke, B. M. ;
Shak, S. ;
Rowinsky, E. K. ;
Xu, L-A ;
Harbison, C. T. ;
Clark, E. A. ;
Mauro, D. J. ;
Khambata-Ford, S. .
BRITISH JOURNAL OF CANCER, 2011, 104 (03) :488-495
[39]   Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer [J].
J B Baker ;
D Dutta ;
D Watson ;
T Maddala ;
B M Munneke ;
S Shak ;
E K Rowinsky ;
L-A Xu ;
C T Harbison ;
E A Clark ;
D J Mauro ;
S Khambata-Ford .
British Journal of Cancer, 2011, 104 :488-495
[40]   CHEMOTHERAPY OF METASTATIC ENDOMETRIAL CANCER [J].
MUSS, HB .
SEMINARS IN ONCOLOGY, 1994, 21 (01) :107-113